Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in men with androgenic alopecia
NCT01904721Phase 2Completed
- Sponsor
- Allergan
- Start
- Aug 2013
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost in androgenetic alopecia (AGA), sponsored by Allergan. Started Aug 2013; status: completed.
02
Drugs
bimatoprost
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01904721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01904721.